Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Molecular Neurodegeneration
|
August 10, 2018
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases
Jason A Chen, Zhongbo Chen, Hyejung Won, et al.
Lancet (London, England)
|
May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial
Gilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Nature Genetics
|
July 26, 2016
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Wouter van Rheenen, Aleksey Shatunov, Annelot M Dekker, et al.
Nature Genetics
|
December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics
|
February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Molecular Neurodegeneration
|
August 10, 2018
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases
Jason A Chen, Zhongbo Chen, Hyejung Won, et al.
Lancet (London, England)
|
May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial
Gilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Nature Genetics
|
July 26, 2016
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Wouter van Rheenen, Aleksey Shatunov, Annelot M Dekker, et al.
Nature Genetics
|
December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics
|
February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Page
of 4